Back to Search
TRISHA CARDILLO, MD
MD
Psychiatry Physician
NPI: 1881222800IndividualAccepts Medicare
Education
OTHER
Class of 2020
Research & Publications (20)
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma.
PMID 19372261·Blood·2009
7-preclinical
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.
PMID 18941114·Blood·2009
4-observational
Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.
PMID 18922911·Cancer Res·2008
7-preclinical
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
PMID 18559529·Cancer Res·2008
7-preclinical
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.
PMID 18025153·Blood·2008
8-other
Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.
PMID 18939816·J Med Chem·2008
8-other
Yeast N(alpha)-terminal acetyltransferases are associated with ribosomes.
PMID 17541948·J Cell Biochem·2008
4-observational
CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
PMID 17875789·Clin Cancer Res·2007
6-review
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
PMID 16344318·J Clin Oncol·2006
8-other
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
PMID 17000696·Clin Cancer Res·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 5635 SUPERIOR DR
LAKELAND, FL 33805 - Phone
- (404) 644-3865
Quick Facts
- NPI
- 1881222800
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile